Table 3 Outcome parameters according to preoperative MPV level and hematocrit levels
From: Mean platelet volume may predict early clinical outcome after coronary artery bypass grafting
Outcome | Preoperative MPV level | Preoperative hematocrit level | ||||
|---|---|---|---|---|---|---|
< 8.75 fL (n=135) | ≥ 8.75 fL (n=70) | p value | > 41.5% (n=137) | ≤ 41.5% (n=68) | p value | |
Combined adverse events (n=37) | 17 (12.6%) | 20 (28.6%) | 0.005* | 16 (11.7%) | 21 (30.9%) | 0.001* |
Postoperative MI (n=21) | 9 (6.7%) | 12 (17.1%) | 0.019* | 10 (7.3%) | 11 (16.2%) | 0.048* |
Mortality (n=8) | 6 (4.4%) | 2 (2.9%) | 0.718† | 4 (2.9%) | 4 (5.9%) | 0.444† |
MACE (n=26) | 13 (9.6%) | 13 (18.6%) | 0.068* | 12 (8.8%) | 14 (20.6%) | 0.017* |
Prolonged ventilation (n=13) | 9 (6.7%) | 4 (5.7%) | 1.000† | 5 (3.6%) | 8 (11.8%) | 0.034† |
Re-hospitalization (n=17) | 8 (5.9%) | 9 (12.9%) | 0.088* | 7 (5.1%) | 10 (14.7%) | 0.019* |
Prolonged ICU stay (days) (n=31) | 16 (11.9%) | 15 (21.4%) | 0.070* | 14 (10.2%) | 17 (25.0%) | 0.005* |
Prolonged hospital stay (days) (n=44) | 27 (20.0%) | 17 (24.3%) | 0.478* | 21 (15.3%) | 23 (33.8%) | 0.002* |